SYDNEY-BASED pharmacy owner and lead applicant in a proposed class action case against Australian Pharmaceutical Industries' (API) banner Priceline Pharmacy (PD 22 Feb), Chris Lemon, plans to launch a disruptive co-operative network, Benepharm, later this year.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 24 Feb 21 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Feb 21
IT IS too early to tell what impact, if any, new advice regarding the rollout of the AstraZeneca (AZ) COVID-19 vaccines in patients under 50 years will have for community pharmacists.
AUSTRALIA’S pandemic response sub-register of recently retired health practitioners, including 1,936 pharmacists, will remain in place until 06 Apr 2022, to support the rollout of COVID-19 vaccines.
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.